コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 inding of complement inhibitors factor H and C4b-binding protein.
2 classical and lectin pathways of complement, C4b-binding protein.
3 uid-phase complement regulators factor H and C4b-binding protein.
4 omologous positions in other CCP-bearing C3b/C4b-binding proteins.
5 ity of microprotein S was not neutralized by C4b-binding protein, a natural inhibitor of native prote
7 binding to the complement regulatory factors C4b-binding protein and factor H and confirmed that the
8 or outer membrane protein of NTHi, P5, binds C4b-binding protein and factor H to promote bacterial se
10 xidized LDL, IgG, amyloid beta peptide 1-42, C4b-binding protein, and factor H, in a CRP concentratio
11 rotein S cofactor function using recombinant C4b-binding protein beta chain significantly reduced the
12 istance, which was confirmed by factor H and C4b-binding protein binding studies, was more often asso
14 ontrast, binding of the complement regulator C4b-binding protein by the M. catarrhalis strains used i
15 an association between beta-chain containing C4b-binding protein (C4bBP-beta+) antigen levels and age
16 of Y. enterocolitica, presumably by binding C4b binding protein (C4BP) and factor H, which are both
17 We demonstrate that the alpha chain of human C4b binding protein (C4BP) binds directly to CD40 on hum
18 previously demonstrated that the binding of C4b binding protein (C4BP) is important for NTHi complem
19 binding of the complement regulatory protein C4b binding protein (C4BP) to the FA19 porin B (PorB), p
20 ontributes to serum resistance by binding to C4b binding protein (C4bp), a complement fluid phase reg
21 low fever virus NS1 directly associated with C4b binding protein (C4BP), a complement regulatory plas
22 issue of Immunity, Brodeur et al. show that C4b binding protein (C4BP), a regulator component of the
23 sides interacting with FH, FH related-1, and C4b binding protein (C4BP), also acquire FH like-1 from
24 urally related soluble complement inhibitors C4b-binding protein (C4BP) and factor H (FH) exert a tig
25 eumococci bind complement inhibitors such as C4b-binding protein (C4BP) and factor H via pneumococcal
26 interaction between the complement inhibitor C4b-binding protein (C4BP) and plasminogen of the fibrin
29 the complement inhibitors factor H (FH) and C4b-binding protein (C4BP) in a human-specific manner, w
31 The classical pathway complement regulator C4b-binding protein (C4BP) is composed of two polypeptid
32 athway of complement down-regulatory protein C4b-binding protein (C4bp) to evade killing by human com
33 trep A) are responsible for recruiting human C4b-binding protein (C4BP) to the bacterial surface, whi
34 the classical complement pathway inhibitor, C4b-binding protein (C4BP), via their porin (Por) molecu
42 ccus evades complement, including binding to C4b-binding protein (C4BP; classical pathway inhibitor)
43 em, factor H (FH) and the alpha chain of the C4b binding protein (C4bpalpha), and included in this st
44 ence of several cofactors, such as factor H, C4b-binding protein, complement receptor 1, and membrane
47 cofactor protein (MCP; CD46), factor H, and C4b binding protein mediate this reaction, known as cofa
48 ieved to interfere with protein S binding to C4b-binding protein resulting in reduced free protein S
50 otein S to the association of protein S with C4b-binding protein, thus establishing the importance of
51 oth a sublethal dose of Escherichia coli and C4b binding protein to assess the impact of inhibiting p
52 that PRELP competitively inhibits binding of C4b-binding protein to bacteria, which enhances membrane
54 uiting to its surface a complement inhibitor C4b-binding protein, which is also a ligand for PRELP.
55 gh-affinity, calcium-stabilized complex with C4b-binding protein, which renders this fraction devoid
56 nd to interact with the complement inhibitor C4b-binding protein, which was suggested to locally down